Shanghai Haixin Group Co

Shanghai Haixin Group Co EBITDA per Share

The EBITDA per Share of Shanghai Haixin Group Co (600851.SS) as of Oct 20, 2026 is 0.04 CNY. In the previous year, EBITDA per Share was 0.16 CNY — a change of -76.18% (lower).

EBITDA per Share

0.04CNY

YoY

-76.18%

Last updated:

EBITDA per Share of Shanghai Haixin Group Co is 2025 0.04 CNY. EBITDA per Share of Shanghai Haixin Group Co was 2024 0.16 CNY. It decreases by -76.18% lower compared to the previous year.

The Shanghai Haixin Group Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.16 CNY
Jan 1, 2019
0.13 CNY
Jan 1, 2020
0.10 CNY
Jan 1, 2021
0.10 CNY
Jan 1, 2022
0.20 CNY
Jan 1, 2023
0.18 CNY
Jan 1, 2024
0.16 CNY
Jan 1, 2025
0.04 CNY
The Shanghai Haixin Group Co EBITDA per Share history
YEAREBITDA per ShareYoY
0.04CNY-76.18%
0.16CNY-14.81%
0.18CNY-7.98%
0.20CNY+93.79%
0.10CNY+2.22%
0.10CNY-22.23%
0.13CNY-19.34%
0.16CNY+44.20%
0.11CNY+85.18%
0.06CNY-42.85%
0.11CNY-70.10%
0.35CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Haixin Group Co Stock analysis

What does Shanghai Haixin Group Co do? Shanghai Haixin Group Co., Ltd. generates revenue through its Textile segment, which produces and sells plush fabrics and clothing, and its Pharmaceutical segment, which manufactures and sells pharmaceutical products. The company also earns income from financial investment business and industrial plant rental management, operating across domestic and overseas markets. Its primary customers include businesses purchasing textiles for clothing production and pharmaceutical buyers seeking medical products, while the financial investment segment attracts institutional investors. The firm's domestic market focus complements its overseas sales channels for both textile and pharmaceutical goods. The Textile segment's plush fabrics and clothing are sold to manufacturers and retailers, while the Pharmaceutical segment's products target healthcare providers and distributors. Financial investments provide passive income streams, and industrial plant rentals contribute to operational revenue. The company's dual-segment approach ensures diversified income sources from both product manufacturing and asset management. Shanghai Haixin's business model relies on the consistent demand for plush fabrics in the apparel industry and pharmaceutical products in healthcare. The financial investment segment leverages capital to generate returns, and industrial plant rentals utilize underused facilities for additional revenue. These segments collectively serve domestic and international clients without relying on external partnerships or third-party services. Shanghai Haixin Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Haixin Group Co stock

EBITDA per Share of Shanghai Haixin Group Co is 0.04 CNY in 2025.

EBITDA per Share of Shanghai Haixin Group Co changed from 0.16 CNY to 0.04 CNY, representing a -76.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Shanghai Haixin Group Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Shanghai Haixin Group Co

All Key Metrics — Shanghai Haixin Group Co